Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06054321
What this trial is testing

Psychopharmacotherapy for Depressive Patients

Who this might be right for
Major Depressive Disorder
Chonnam National University Hospital 400
Not applicableStudy completedNCT03272230
What this trial is testing

Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System

Who this might be right for
ApathyBehavioral Variant Frontotemporal Dementia (bvFTD)Disinhibition+1 more
Institut National de la Santé Et de la Recherche Médicale, France 66
Post-approval studies (Phase 4)Study completedNCT01473381
What this trial is testing

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 1,162
Not applicableStudy completedNCT00151372
What this trial is testing

Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients

Who this might be right for
Pulmonary Disease, Chronic ObstructiveMajor Depression
Weill Medical College of Cornell University 141
Not applicableUnknownNCT05019300
What this trial is testing

Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.

Who this might be right for
Covid19Neurocognitive Dysfunction
Pontificia Universidad Catolica de Chile 80
Large-scale testing (Phase 3)Study completedNCT00095745
What this trial is testing

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,002
Not applicableUnknownNCT04963907
What this trial is testing

Alpha-Stim AID and Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Electromedical Products International, Inc. 230
Post-approval studies (Phase 4)Study completedNCT04220996
What this trial is testing

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)

Who this might be right for
MDDAnxiety Disorders
H. Lundbeck A/S 100
Post-approval studies (Phase 4)Study completedNCT02188121
What this trial is testing

Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients

Who this might be right for
Serious Mental IllnessSchizophreniaSchizoaffective Disorder+4 more
Mclean Hospital 227
Testing effectiveness (Phase 2)Study completedNCT00290914
What this trial is testing

Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Pharmacology Research Institute
Not applicableStudy completedNCT00613912
What this trial is testing

Advanced MRI in Major Depression

Who this might be right for
Depressive Disorder, Major
University of Aarhus 49
Not applicableEnded earlyNCT05109195
What this trial is testing

A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 7
Not applicableStudy completedNCT01793324
What this trial is testing

EMR Data to Assess Monitoring of Patients Treated With Quetiapine

Who this might be right for
SchizophreniaBipolar DisorderMajor Depressive Disorder
AstraZeneca 6,153
Testing effectiveness (Phase 2)Study completedNCT01309945
What this trial is testing

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Who this might be right for
Depression
Bristol-Myers Squibb 889
Large-scale testing (Phase 3)Ended earlyNCT00637494
What this trial is testing

Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Who this might be right for
Psychotic DepressionSevere Major Depression With Psychotic FeaturesPsychosis
Corcept Therapeutics 292
Post-approval studies (Phase 4)UnknownNCT00335205
What this trial is testing

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Who this might be right for
Bipolar DisorderMajor Depressive Disorder
Sheba Medical Center 60
Not applicableStudy completedNCT02667353
What this trial is testing

Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression

Who this might be right for
Depression
Universitaire Ziekenhuizen KU Leuven 110
Not applicableStudy completedNCT01536756
What this trial is testing

Effectiveness of a Structured Physical Rehabilitation Program for Chinese Patients With Depressive Disorders

Who this might be right for
Depressive Disorders
Kowloon Hospital, Hong Kong 84
Testing effectiveness (Phase 2)Study completedNCT06558344
What this trial is testing

Test Different Doses of BI 1569912 in People With Depression

Who this might be right for
Depressive Disorder, Major
Boehringer Ingelheim 225
Large-scale testing (Phase 3)Ended earlyNCT01123707
What this trial is testing

To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 173
Next Page